M&A - Pharmaceutical Executive



Structural Forces Impacting the Pharmaceutical Industry

October 15, 2013

Patrick Lindsay, president of UBC sits down with Editorial Director Bill Loony to discusses the issues UBC confronts as it offers support services to pharmaceutical companies

Driven to License

February 1, 2007

Goodbye, M&As. Hello, L&As. The new trend in business development is licensing deals and acquisitions. The hot categories are CNS, oncology, and immunology. Now let's get bizzy.

Slow Deal Flow?

September 1, 2006

Roche, Johnson & Johnson, and Teva have demonstrated formidable deal making for many years. But generally, business development capabilities in the pharma industry remain very patchy, with the number of poor performers far out-weighing the good.


Click here